Gilead Sciences Inc.’s stock jumped early Thursday after the company said its experimental injection for HIV prevention was found 100% effective in a late-stage trial.
More Stories
Jamie Dimon: Only 5% of everyday Americans probably know about the Fed’s historic interest-rate cut
JPMorgan Chase CEO Jamie Dimon suggests the half-point interest-rate cut is “a minor thing” that Wall Street — not Main...
Uranium ETFs rally amid plans to revive nuclear reactor in Microsoft agreement
Constellation Energy said Friday it plans to restart a nuclear reactor at Three Mile Island.
The Fed rate cut scared me. Where should I invest my $127,000 in savings now?
This reader wonders whether CD rates, high-yield savings accounts and bond ladders are still smart moves, even if interest rates...
The fan who caught Shohei Ohtani’s 50th home-run ball could make $500,000
Aaron Judge’s 62nd home-run ball in 2022 sold for $1.5 million at auction
How to invest if you believe the Fed can’t stop the economy from falling apart
Also: What to expect for loan interest rates, how Social Security survivor and spousal benefits work, and advice from the...
With meme stocks in a lull, here’s where retail investors may turn their attention next
The dynamics that fueled the meme-stock frenzy have not gone away, according to a recent study.